Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/1780
Title: | Remedial effects of novel 2,3-disubstituted thiazolidin-4-ones in chemical mediated inflammation | Authors: | Mathew, Geetha ;Mudgal, J.;Gowdra, V.S.;Nayak, P.G.;Reddy, N.D.;Namdeo, N.;Kumar, R.R.;Kantamaneni, C.;Chamallamudi, M.R.;Nampurath, G.K. | Issue Date: | Mar-2014 | Source: | March 2014, Volume 210, pp. 34 - 42 | Journal title: | Chemico-Biological Interactions | Department: | Pharmacy | Abstract: | Three thiazolidin-4-one derivatives were synthesized, purified and characterized by chromatographic and spectroscopic methods. In the in vitro assays, these compounds inhibited reactive oxygen species (ROS), nitrite and cytokine generation in RAW 264.7 murine macrophages and whole blood. These derivatives attenuated carrageenan-induced acute inflammation in rats. The most effective compound 4C possessed identical anti-inflammatory action at two doses (50 and 100 mg/kg). Further, the effect of compound 4C on locally induced inflammatory mediators was investigated in carrageenan-induced air pouch inflammation in rats. In this model, compound 4C inhibited the cytokines, tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 (systemic and local). Additionally, compound 4C was able to reduce locally elevated prostaglandin-E(2) (PGE(2)). Inhibition of leukocyte infiltration by compound 4C was correlated with reduced locally released myeloperoxidase (MPO). To conclude, compound 4C corrected the inflammatory condition by negative effect on cytokine (TNF-alpha, IL-6) network and prostaglandin-E(2) generation. | URI: | https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1780 | DOI: | 10.1016/j.cbi.2013.12.012 | Pubmed: | https://pubmed.ncbi.nlm.nih.gov/24412305/ | ISSN: | 0009-2797 | Publicaton type: | Journal Article | Keywords: | Research |
Appears in Collections: | Health Service Research |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.